Skip to main content

Peer Review reports

From: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Original Submission
15 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Nov 2022 Reviewed Reviewer Report - Cuizhi Geng
19 Dec 2022 Reviewed Reviewer Report - Huiping Li
20 Dec 2022 Author responded Author comments - Cengiz Karacin
Resubmission - Version 3
20 Dec 2022 Submitted Manuscript version 3
23 Dec 2022 Author responded Author comments - Cengiz Karacin
Resubmission - Version 4
23 Dec 2022 Submitted Manuscript version 4
2 Jan 2023 Reviewed Reviewer Report - Huiping Li
2 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
3 Feb 2023 Editorially accepted
10 Feb 2023 Article published 10.1186/s12885-023-10609-8

You can find further information about peer review here.

Back to article page